Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience

Abstract
A Corrigendum on Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience by Lin, S.-F., Hu, H.-H., Ho, B.-L., Chen, C.-H., Chan, L., Lin, H.-J., Sun, Y., Lin, Y-Y., Chen, P-L., Lin, S-K., Wei, C-Y., Lin, Y-T., Lee, J-T., Chao, A-C., and Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group. (2021). Front. Neurol. 12:628077. doi: 10.3389/fneur.2021.628077 In the published article, there were errors in affiliations 1–5. Instead of “1 School of Public Health, College of Public Health, Taipei, Taiwan, 2 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 3 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 4 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan, 5 Department of Health Care Administration, Chung-Hwa University of Medical Technology, Tainan, Taiwan” it should be “1 School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, 2 Department of Critical Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan, 3 Department of Clinical Pathology, Taipei Medical University, Taipei, Taiwan, 4 Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 5 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Keywords: aspirin, clopidogrel, stroke, intracranial hemorrhage, intravenous thrombolysis Citation: Lin S-F, Hu H-H, Ho B-L, Chen C-H, Chan L, Lin H-J, Sun Y, Lin Y-Y, Chen P-L, Lin S-K, Wei C-Y, Lin Y-T, Lee J-T, Chao A-C and Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group (2021) Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience. Front. Neurol. 12:737437. doi: 10.3389/fneur.2021.737437 Received: 07 July 2021; Accepted: 08 July 2021; Published: 17 September 2021. Approved by: Copyright © 2021 Lin, Hu, Ho, Chen, Chan, Lin, Sun, Lin, Chen, Lin, Wei, Lin, Lee, Chao and Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: A-Ching Chao, achch@cc.kmu.edu.tw; Han-Hwa Hu, hanhwa@hotmail.com